Prelude Capital Management’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $392K | Buy |
39,349
+23,005
| +141% | +$229K | 0.04% | 513 |
|
|
2025
Q1 | $97.6K | Buy |
16,344
+5,736
| +54% | +$34.2K | 0.01% | 956 |
|
|
2024
Q4 | $81.5K | Sell |
10,608
-3,269
| -24% | -$25.1K | 0.01% | 985 |
|
|
2024
Q3 | $142K | Buy |
+13,877
| New | +$142K | 0.01% | 1015 |
|
|
2024
Q2 | – | Sell |
-17,428
| Closed | -$238K | – | 1259 |
|
|
2024
Q1 | $238K | Buy |
+17,428
| New | +$238K | 0.01% | 914 |
|
|
2021
Q1 | – | Sell |
-6,478
| Closed | -$219K | – | 1242 |
|
|
2020
Q4 | $219K | Buy |
+6,478
| New | +$219K | 0.01% | 631 |
|